Cancer Network presents MEDSIR’s study Phergain-2

Actualizado: mar 23

With more than 22.000 followers on Twitter and almost 10.000 on Facebook, Cancer Network Oncology Journal is one of the most reputable online journals in Oncology.

Last month they featured our latest clinical trial Phergain-2 on their website and we truly appreciate the dissemination of such an important study, which can potentially help many patients with breast cancer avoid chemotherapy and all its side effects without any decrease in the clinical efficacy of their other treatments.

Link to the article at Cancer Network

42 vistas0 comentarios

Entradas Recientes

Ver todo